tiprankstipranks
Everest Medicines Ltd. (HK:1952)
:1952
Hong Kong Market
1952
Everest Medicines Ltd.
RESEARCH TOOLSreports
Want to see HK:1952 full AI Analyst Report?

Everest Medicines Ltd. (1952) Ratios

4 Followers

Everest Medicines Ltd. Ratios

HK:1952's free cash flow for Q2 2025 was ¥0.67. For the 2025 fiscal year, HK:1952's free cash flow was decreased by ¥ and operating cash flow was ¥-0.62. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 4.89 4.89 2.54 8.36 3.92
Quick Ratio
 4.85 4.77 2.52 8.29 3.91
Cash Ratio
 2.67 3.96 1.11 1.74 0.56
Solvency Ratio
 -0.23 -0.09 -1.05 -0.95 -0.21
Operating Cash Flow Ratio
 -0.26 -0.16 -0.86 -2.56 -1.33
Short-Term Operating Cash Flow Coverage
 -2.44 -1.18 -1.45 -33.94 -2.73
Net Current Asset Value
¥ 1.84B¥ 1.85B¥ 1.13B¥ 1.70B¥ 2.45B
Leverage Ratios
Debt-to-Assets Ratio
 0.14 0.14 0.12 0.09 0.08
Debt-to-Equity Ratio
 0.17 0.17 0.14 0.10 0.09
Debt-to-Capital Ratio
 0.15 0.15 0.12 0.09 0.09
Long-Term Debt-to-Capital Ratio
 0.13 0.13 0.01 0.08 <0.01
Financial Leverage Ratio
 1.29 1.29 1.22 1.16 1.17
Debt Service Coverage Ratio
 -3.18 0.59 -1.36 -16.29 -0.46
Interest Coverage Ratio
 0.00 -16.60 -50.34 -40.45 -45.93
Debt to Market Cap
 0.09 0.08 0.04 0.08 0.10
Interest Debt Per Share
 2.85 2.82 1.86 1.70 1.82
Net Debt to EBITDA
 3.88 8.07 0.46 0.02 -0.22
Profitability Margins
Gross Profit Margin
69.11%60.08%74.84%72.67%63.69%
EBIT Margin
-51.02%-22.64%-110.41%-652.26%-1889.34%
EBITDA Margin
-36.43%-13.46%-94.82%-591.29%-1554.97%
Operating Profit Margin
-83.86%-22.64%-158.07%-740.67%-2007.50%
Pretax Profit Margin
-70.03%-35.06%-147.36%-670.57%-1933.04%
Net Profit Margin
-70.03%-17.45%-147.36%-670.57%-1933.11%
Continuous Operations Profit Margin
-70.03%-17.45%-147.36%-670.57%-1933.11%
Net Income Per EBT
100.00%49.76%100.00%100.00%100.00%
EBT Per EBIT
83.50%154.89%93.23%90.54%96.29%
Return on Assets (ROA)
-6.65%-4.24%-21.00%-14.63%-3.74%
Return on Equity (ROE)
-10.55%-5.47%-25.57%-17.00%-4.37%
Return on Capital Employed (ROCE)
-8.85%-6.12%-26.82%-17.04%-4.47%
Return on Invested Capital (ROIC)
-8.72%-3.00%-24.00%-16.92%-4.15%
Return on Tangible Assets
-9.58%-6.11%-38.51%-25.99%-5.88%
Earnings Yield
-4.90%-2.60%-7.14%-14.24%-5.41%
Efficiency Ratios
Receivables Turnover
 1.30 3.03 1.94 2.53 2.45
Payables Turnover
 0.98 3.25 3.86 0.70 0.04
Inventory Turnover
 6.22 7.95 12.63 1.82 0.40
Fixed Asset Turnover
 1.04 2.53 1.09 0.18 0.02
Asset Turnover
 0.09 0.24 0.14 0.02 <0.01
Working Capital Turnover Ratio
 0.30 0.85 0.41 0.05 <0.01
Cash Conversion Cycle
 -31.21 54.28 122.61 -173.14 -7.39K
Days of Sales Outstanding
 281.34 120.49 188.37 144.51 148.77
Days of Inventory Outstanding
 58.69 45.94 28.91 200.92 914.43
Days of Payables Outstanding
 371.23 112.15 94.67 518.57 8.45K
Operating Cycle
 340.03 166.43 217.28 345.43 1.06K
Cash Flow Ratios
Operating Cash Flow Per Share
 -0.56 -0.33 -2.12 -2.46 -3.88
Free Cash Flow Per Share
 -0.63 -0.51 -2.32 -3.31 -5.34
CapEx Per Share
 0.07 0.19 0.20 0.85 1.45
Free Cash Flow to Operating Cash Flow
 1.13 1.57 1.10 1.35 1.37
Dividend Paid and CapEx Coverage Ratio
 -7.45 -1.76 -10.39 -2.89 -2.67
Capital Expenditure Coverage Ratio
 -7.45 -1.76 -10.39 -2.89 -2.67
Operating Cash Flow Coverage Ratio
 -0.20 -0.12 -1.18 -1.51 -2.16
Operating Cash Flow to Sales Ratio
 -0.28 -0.07 -0.96 -6.11 -90.35
Free Cash Flow Yield
-2.06%-1.54%-5.11%-17.46%-34.78%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -20.41 -38.53 -14.01 -7.02 -18.47
Price-to-Sales (P/S) Ratio
 15.43 6.72 20.64 47.08 357.07
Price-to-Book (P/B) Ratio
 1.75 2.11 3.58 1.19 0.81
Price-to-Free Cash Flow (P/FCF) Ratio
 -48.63 -64.85 -19.58 -5.73 -2.88
Price-to-Operating Cash Flow Ratio
 -51.09 -101.63 -21.47 -7.71 -3.95
Price-to-Earnings Growth (PEG) Ratio
 -0.43 0.52 -0.70 -0.03 0.24
Price-to-Fair Value
 1.75 2.11 3.58 1.19 0.81
Enterprise Value Multiple
 -38.47 -41.85 -21.31 -7.95 -23.18
Enterprise Value
 9.09B 9.37B 14.28B 5.92B 4.61B
EV to EBITDA
 -38.47 -41.85 -21.31 -7.95 -23.18
EV to Sales
 14.02 5.64 20.21 46.98 360.50
EV to Free Cash Flow
 -44.17 -54.37 -19.17 -5.72 -2.90
EV to Operating Cash Flow
 -50.10 -85.20 -21.01 -7.69 -3.99
Tangible Book Value Per Share
 9.87 9.57 5.67 7.81 10.89
Shareholders’ Equity Per Share
 16.30 15.77 12.69 15.87 19.00
Tax and Other Ratios
Effective Tax Rate
 0.00 0.50 0.00 0.00 >-0.01
Revenue Per Share
 1.99 4.94 2.20 0.40 0.04
Net Income Per Share
 -1.40 -0.86 -3.24 -2.70 -0.83
Tax Burden
 1.00 0.50 1.00 1.00 1.00
Interest Burden
 1.37 1.55 1.33 1.03 1.02
Research & Development to Revenue
 0.51 0.27 0.75 4.29 63.30
SG&A to Revenue
 1.02 0.56 1.07 1.31 21.62
Stock-Based Compensation to Revenue
 0.17 0.00 0.13 0.58 16.14
Income Quality
 0.40 0.38 0.65 0.91 4.67
Currency in CNY